Greg Jones Articles

Feb 14, 2020 by Greg Jones

Amgen: A Quality Stock for the Long-Term Investor

Amgen is trading at a discount to the market. Recent developments with its pipeline should lead to a rerating of its stock.

Feb 11, 2020 by Greg Jones

AbbVie Is a Dividend Growth Stock at a Bargain Price

AbbVie reported fourth-quarter results that topped expectations. Its valuation discount is no longer warranted.

Feb 7, 2020 by Greg Jones

Gilead Sciences: Still on the Path to Recovery

Gilead released a mixed fourth-quarter earnings report. Longer-term investors should stick with the stock.

Feb 4, 2020 by Greg Jones

Altria's Earnings: Bull Case Still Intact for This Dividend Growth Stock

Altria's shares fell on disappointing earnings. However, a closer look suggests that the stock remains attractive for long-term investors.

Jan 30, 2020 by Greg Jones

Wells Fargo: Not Ready to Throw in the Towel

The news seems to go from bad to worse for Wells Fargo. But with a new CEO on board, could we be on the verge of a new dawn for the stock?

Jan 28, 2020 by Greg Jones

IBM: Is Big Blue Set for Sustained Growth?

IBM released earnings that were better than expected. Although the results were mixed, investors should be taking a closer look at the stock.

Jan 2, 2020 by Greg Jones

(For Keith)3 Stocks to Buy in a Bear Market

A significant correction is an inevitability at some point, if history is any guide. Here are three stocks to buy if the opportunity arises.

Dec 26, 2019 by Greg Jones

Why Cisco Systems is Overdue for a Rebound

Macroeconomic factors have clouded Cisco's recent performance. With those clouds now parting, the stock deserves a second look.

Dec 18, 2019 by Greg Jones

Bottom-Fishing The Energy Sector With Chevron

The energy sector seems overdue for a rebound. Chevron may be the best way to play it.

Dec 12, 2019 by Greg Jones

Is Warren Buffett's Berkshire Hathaway Still a Good Bet?

Berkshire has lagged the market over the recent past. It's time for the shares to play catch up.

cloud computing computer key getty 6. 2. 17 (1)

Dec 10, 2019 by Greg Jones

What Would Warren Buffett's Mentor Think About Accenture?

On many dimensions, Accenture qualifies as a great company. But is it a great investment?

Dec 6, 2019 by Greg Jones

Bristol Myers Squibb: A Cash-Generating Machine at a Cheap Price

This big pharma stock provides value in an increasingly expensive market.

Dividends with hand drawing line going up

Nov 26, 2019 by Greg Jones

Why AbbVie Is a Dividend Growth Stock That's Too Cheap to Ignore

The Allergan deal will cement AbbVie’s position as a diversified pharmaceutical company with sustainable growth. It’s time for the shares to play catchup.

Nov 23, 2019 by Greg Jones

Is IBM Ready for a Big Rebound?

IBM has thus far missed out on the technology rally. Its acquisition of Red Hat earlier this year may be a game changer.

Nov 18, 2019 by Greg Jones

Wells Fargo: Time To Climb Aboard The Stagecoach

With a new CEO on board, Wells Fargo can start to put its problems behind it

marijuana cigarrete in a hand with smoke surrounding

Nov 12, 2019 by Greg Jones

Is Altria Going Up in Smoke or Just Going Up?

Persistent bad news has driven the tobacco company to its lowest valuation in 10 years. It’s time to have a second look.

Nov 7, 2019 by Greg Jones

Is The Future Finally Looking Up For Gilead Sciences?

It’s been a rough ride for Gilead Sciences. But the biotech may soon be sailing through smoother seas.

Greg Jones

Recent Articles by Greg Jones